Last Updated: April 27, 2024
rituxanforgpampa.com has 2 NS records, 3 A records, 2 AAAA records, 0 MX records, and 1 TXT records. Name servers for rituxanforgpampa.com are lara.ns.cloudflare.com, alan.ns.cloudflare.com. A records for rituxanforgpampa.com are , 104.18.8.232, 104.18.9.232. AAAA records for rituxanforgpampa.com are 2606:4700:0:0:0:0:6812:9e8, 2606:4700:0:0:0:0:6812:8e8. We have observed rituxanforgpampa.com to have 2 subdomains. A subdomain count of 2 is considered a small digital footprint. The domain's primary website is hosted on a cloudflare web server at 104.18.28.132 in United States. The website's description is: "learn about rituxan® (rituximab), granulomatosis with polyangiitis (gpa) and microscopic polyangiitis (mpa) treatment used with glucocorticoids. see full safety and boxed warning for more information." As of April 27, 2024, rituxanforgpampa.com does not have any threat intelligence reports of concern.
Search DigitalStakeout Footprint to find another asset.
No DNS A records
2606:4700:0:0:0:0:6812:9e8
2606:4700:0:0:0:0:6812:8e8
No DNS MX records
lara.ns.cloudflare.com
alan.ns.cloudflare.com
rituxanforgpampa.com. 300 IN TXT "v=spf1 -all"
rituxanforgpampa.com has 2 subdomains in our inventory.
cloudflare
104.18.28.132
United States
og:site_name: rituxan
og:type: website
og:locale: en_us
og:title: rituxan® (rituximab) treatment for gpa & mpa patient
og:description: learn about rituxan® (rituximab), granulomatosis with polyangiitis (gpa) and microscopic polyangiitis (mpa) treatment used with glucocorticoids. see full safety and boxed warning for more information.
og:url: https://www.rituxan.com/gpa-mpa.html
og:image: https://www.rituxan.com/content/dam/gene/rituxan/ra/logos/rituxan-patient-logo.genecoreimg.1200.png
og:image:type: image/png
og:image:width: 450
og:image:height: 129
{"message_type": "certificate_update", "data": {"leaf_cert": {"not_after": 1645358400, "signature_algorithm": "sha256, rsa", "extensions": {"subjectKeyIdentifier": "E2:AC:7E:1F:2B:C0:40:D5:03:25:84:A4:70:45:7D:8A:1C:57:44:7B", "authorityKeyIdentifier": "keyid:90:58:FF:B0:9C:75:A8:51:54:77:B1:ED:F2:A3:43:16:38:9E:6C:C5\n", "extendedKeyUsage": "TLS Web server authentication, TLS Web client authentication", "subjectAltName": "DNS:enspryng.com, DNS:avastin.com, DNS:cathflo.com, DNS:huntingtonsdiseasehcp.com, DNS:genentech-pro.com, DNS:pulmozyme.com, DNS:genentech-access.com, DNS:adjuvantperjeta.com, DNS:examinebiosimilars.com, DNS:discovertrk.com, DNS:geographicatrophy.com, DNS:her2treatment.com, DNS:tnkase.com, DNS:caremanagermsguide.com, DNS:commonclaimsmistakesvideo.com, DNS:researchcancerimmunotherapy.com, DNS:ipfrally.com, DNS:evrysdi-hcp.com, DNS:erivedge.com, DNS:cellcept.com, DNS:xolairhcp.com, DNS:xolair.com, DNS:esbriethcp.com, DNS:top5claimsmistakesvideo.com, DNS:msvoice.com, DNS:evrysdi.com, DNS:rituxanforgpampa-hcp.com, DNS:genentech-forum.com, DNS:activase.com, DNS:tecentriq.com, DNS:tamiflu.com, DNS:herceptin.com, DNS:whyimmunotherapy.com, DNS:pinkribbonbottle.com, DNS:asthmainflammation.com, DNS:drugpricinglaw.com, DNS:biooncology.com, DNS:ensprynghcp.com, DNS:actemra.com, DNS:kadcyla.com, DNS:esbriet.com, DNS:transplantaccessservices.com, DNS:perjeta.com, DNS:valcyte.com, DNS:enspryng-hcp.com, DNS:herceptinhylecta.com, DNS:rituxan.com, DNS:knowipfnow.com, DNS:rituxanforra.com, DNS:genentech-medicines.com, DNS:nutropin.com, DNS:alecensa.com, DNS:huntingtonsdisease.com, DNS:tecentriq-hcp.com, DNS:venclexta.com, DNS:cotellic.com, DNS:genentechhemophilia.com, DNS:fuzeon.com, DNS:lucentis.com, DNS:gazyva.com, DNS:actemrahcp.com, DNS:rituxanforgpampa.com, DNS:emicizumabinfo.com, DNS:rozlytrek.com, DNS:rarediseasesignup.com, DNS:bladdercancerinformation.com, DNS:mycareforward.com, DNS:faceipf.com, DNS:omliago.com, DNS:hemlibra.com, DNS:author.aem.gene.com, DNS:ocrelizumabinfo.com, DNS:venclextahcp.com, DNS:avastin-hcp.com, DNS:polivy.com, DNS:xofluza.com, DNS:rituxanforra-hcp.com, DNS:rethinksma.com, DNS:rituxanforpv.com, DNS:ocrevus.com, DNS:esbrietstories.com, DNS:rituxanhycela.com, DNS:aem.gene.com", "crlDistributionPoints": "Full Name:\n URI:http://cdp.geotrust.com/GeoTrustRSACA2018.crl", "keyUsage": "Digital Signature, Key Encipherment", "certificatePolicies": "Policy: 2.23.140.1.2.2\nPolicy: 2.16.840.1.114412.1.1\n CPS: https://www.digicert.com/CPS", "ctlSignedCertificateTimestamp": "BIIBawFpAHYApLkJkLQYWBSHuxOizGdwCjw1mAT5G9-443fNDsgN3BAAAAFwQrmLbgAABAMARzBFAiB38S7xFKYIrQLO7IZWfyObM6pHpbFhV-V3haJaXZzUMAIhAI1zrMwxFBj4dZ6ihQk1Q_dyLE_UpeDQwhFSWaZW9EySAHYAIkVFB1lVJFaWP6Ev8fdthuAjJmOtwEt_XcaDXG7iDwIAAAFwQrmLaAAABAMARzBFAiAg2KxAgJpinJim23SKhNBd6lMu8L0Pb9spAgNklwo1AQIhAOqSChgHPsB50Woydr7fN-GnRSRxFqzJVgVUgm6lGZwPAHcAUaOw9f0BeZxWbbg3eI8MpHrMGyfL956IQpoN_tSLBeUAAAFwQrmLiQAABAMASDBGAiEA5yJW8pAGq8adL9xEETL_yTKmVK7jSaLqqcEAQ_160mUCIQDgfKcSGZnoPpFN31hwJPQPwkGGizrHnFqgkvt9cjz_iA==", "authorityInfoAccess": "CA Issuers - URI:http://cacerts.geotrust.com/GeoTrustRSACA2018.crt\nOCSP - URI:http://status.geotrust.com\n", "basicConstraints": "CA:FALSE"}, "fingerprint": "30:3E:5C:66:D6:1A:DF:1B:63:51:EA:EB:35:B9:6D:E2:11:84:87:C0", "all_domains": ["alecensa.com", "aem.gene.com", "genentechhemophilia.com", "rituxanforra.com", "geographicatrophy.com", "enspryng.com", "venclextahcp.com", "rituxanforgpampa.com", "emicizumabinfo.com", "nutropin.com", "gazyva.com", "rituxanforpv.com", "venclexta.com", "author.aem.gene.com", "rituxan.com", "polivy.com", "ocrevus.com", "erivedge.com", "xofluza.com", "esbriet.com", "drugpricinglaw.com", "her2treatment.com", "rituxanforra-hcp.com", "valcyte.com", "rozlytrek.com", "xolairhcp.com", "mycareforward.com", "kadcyla.com", "examinebiosimilars.com", "avastin.com", "asthmainflammation.com", "tecentriq-hcp.com", "lucentis.com", "cotellic.com", "knowipfnow.com", "genentech-medicines.com", "genentech-forum.com", "huntingtonsdisease.com", "pulmozyme.com", "esbriethcp.com", "perjeta.com", "discovertrk.com", "evrysdi.com", "biooncology.com", "activase.com", "actemra.com", "esbrietstories.com", "commonclaimsmistakesvideo.com", "faceipf.com", "ocrelizumabinfo.com", "enspryng-hcp.com", "fuzeon.com", "xolair.com", "avastin-hcp.com", "adjuvantperjeta.com", "tecentriq.com", "cathflo.com", "caremanagermsguide.com", "tnkase.com", "transplantaccessservices.com", "ensprynghcp.com", "cellcept.com", "rarediseasesignup.com", "hemlibra.com", "msvoice.com", "evrysdi-hcp.com", "herceptinhylecta.com", "herceptin.com", "actemrahcp.com", "tamiflu.com", "bladdercancerinformation.com", "genentech-pro.com", "huntingtonsdiseasehcp.com", "researchcancerimmunotherapy.com", "rethinksma.com", "genentech-access.com", "rituxanforgpampa-hcp.com", "omliago.com", "ipfrally.com", "top5claimsmistakesvideo.com", "whyimmunotherapy.com", "pinkribbonbottle.com", "rituxanhycela.com"], "serial_number": "37C5417721ED4EE9C3CEA8A974A278A", "subject": {"C": "CH", "CN": "aem.gene.com", "L": "Basel", "O": "F. Hoffmann-La Roche AG", "ST": null, "emailAddress": null, "OU": "Interactive Marketing", "aggregated": "/C=CH/CN=aem.gene.com/L=Basel/O=F. Hoffmann-La Roche AG/OU=Interactive Marketing"}, "not_before": 1581638400, "issuer": {"C": "US", "CN": "GeoTrust RSA CA 2018", "L": null, "O": "DigiCert Inc", "ST": null, "emailAddress": null, "OU": "www.digicert.com", "aggregated": "/C=US/CN=GeoTrust RSA CA 2018/O=DigiCert Inc/OU=www.digicert.com"}}, "cert_link": "https://sabre.ct.comodo.com/ct/v1/get-entries?start=229863629&end=229863629", "source": {"url": "https://sabre.ct.comodo.com/", "name": "Sectigo 'Sabre' CT log"}, "update_type": "X509LogEntry", "seen": 1680462102.775508, "cert_index": 229863629}}